1921
Volume 94, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

We conducted a prospective cohort study to assess adherence to malaria chemoprophylaxis, reasons for nonadherence, and use of other personal protective measures against malaria. We included adults traveling to malaria-endemic countries who were prescribed malaria chemoprophylaxis during a pre-travel consultation at three travel clinics in the Boston area and who completed three or more surveys: pre-travel, at least one weekly during travel, and post-travel (2–4 weeks after return). Of 370 participants, 335 (91%) took malaria chemoprophylaxis at least once and reported any missed doses; 265 (79%) reported completing all doses during travel. Adherence was not affected by weekly versus daily chemoprophylaxis, travel purpose, or duration of travel. Reasons for nonadherence included forgetfulness, side effects, and not seeing mosquitoes. Main reasons for declining to take prescribed chemoprophylaxis were peer advice, low perceived risk, and not seeing mosquitoes. Of 368 travelers, 79% used insect repellent, 46% used a bed net, and 61% slept in air conditioning at least once. Because travelers may be persuaded to stop taking medication by peer pressure, not seeing mosquitoes, and adverse reactions to medications, clinicians should be prepared to address these barriers and to empower travelers with strategies to manage common side effects of antimalarial medications.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0565
2016-01-06
2017-09-20
Loading full text...

Full text loading...

/deliver/fulltext/14761645/94/1/136.html?itemId=/content/journals/10.4269/ajtmh.15-0565&mimeType=html&fmt=ahah

References

  1. Centers for Disease Control and Prevention, 2015. Malaria Cases in U.S. Hit 40-Year High. Available at: http://www.cdc.gov/features/malaria/. Accessed February 19, 2015.
  2. Cullen KA, Arguin PM, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, , 2013. Malaria surveillance–United States, 2011. MMWR Surveill Summ 62: 117.
  3. Laver SM, Wetzels J, Behrens RH, , 2001. Knowledge of malaria, risk perception, and compliance with prophylaxis and personal and environmental preventive measures in travelers exiting Zimbabwe from Harare and Victoria Falls International Airport. J Travel Med 8: 298303.[Crossref]
  4. Arguin PM, Tan KR, Brunette GW, , 2014. Malaria. , ed. CDC Health Information for International Travel 2014. New York, NY: Oxford University Press, 228248.
  5. Gershman M, Jentes ES, Sommers T, Staples EJ, Tan KR, Arguin PM, Steel SF, Brunette GW, , 2012. Yellow fever and malaria information, by country. , ed. CDC Health Information for International Travel 2012. New York, NY: Oxford University Press, 348396.
  6. Tan KR, Mali S, Arguin PM, Brunette GW, , 2009. Malaria risk information and prophylaxis by country. , ed. CDC Health Information for International Travel 2010. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, 143159.
  7. Belderok SM, van den Hoek A, Roeffen W, Sauerwein R, Sonder GJ, , 2013. Adherence to chemoprophylaxis and Plasmodium falciparum anti-circumsporozoite seroconversion in a prospective cohort study of Dutch short-term travelers. PLoS One 8: e56863.[Crossref]
  8. DePetrillo JC, Singer C, Bergagnini IA, Kolakowski P, Edwards B, Smith MA, , 2010. Assessment of adherence to atovaquone-proguanil prophylaxis in travelers. J Travel Med 17: 217220.[Crossref]
  9. Goodyer L, Rice L, Martin A, , 2011. Choice of and adherence to prophylactic antimalarials. J Travel Med 18: 245249.[Crossref]
  10. Vliegenthart-Jongbloed K, de Mendonca Melo M, van Wolfswinkel ME, Koelewijn R, van Hellemond JJ, van Genderen PJ, , 2013. Severity of imported malaria: protective effect of taking malaria chemoprophylaxis. Malar J 12: 265.[Crossref]
  11. Leshem E, Meltzer E, Stienlauf S, Kopel E, Schwartz E, , 2014. Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-saharan Africa. J Travel Med 21: 8285.[Crossref]
  12. Siikamaki H, Kivela P, Lyytikainen O, Kantele A, , 2013. Imported malaria in Finland 2003–2011: prospective nationwide data with rechecked background information. Malar J 12: 93.[Crossref]
  13. Anabwani G, Canfield CJ, Hutchinson DB, , 1999. Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children. Pediatr Infect Dis J 18: 456461.[Crossref]
  14. Bouchaud O, Monlun E, Muanza K, Fontanet A, Scott T, Goetschel A, Chulay JD, Le Bras J, Danis M, Le Bras M, Coulaud JP, Gentilini M, , 2000. Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in non-immune adults: a randomized comparative trial. Am J Trop Med Hyg 63: 274279.
  15. Hogh B, Clarke PD, Camus D, Nothdurft HD, Overbosch D, Günther M, Joubert I, Kain KC, Shaw D, Roskell NS, Chulay JD, Malarone International Study Team, , 2000. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Lancet 356: 18881894.[Crossref]
  16. van Vugt M, Leonardi E, Phaipun L, Slight T, Thway KL, McGready R, Brockman A, Villegas L, Looareesuwan S, White NJ, Nosten F, , 2002. Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil. Clin Infect Dis 35: 14981504.[Crossref]
  17. Schlagenhauf P, Petersen E, , 2008. Malaria chemoprophylaxis: strategies for risk groups. Clin Microbiol Rev 21: 466472.[Crossref]
  18. Oomen JMV, de Wolf J, Jobin WR, , 1990. Health and Irrigation. Wageningen, The Netherlands: International Institute for Land Reclamation and Improvement.
  19. Centers for Disease Control and Prevention, 2013. Anopheles Mosquitoes. Available at: http://www.cdc.gov/malaria/about/biology/mosquitoes/. Accessed August 25, 2013.
  20. Adachi K, Coleman MS, Khan N, Jentes ES, Arguin P, Rao SR, LaRocque RC, Sotir MJ, Brunette G, Ryan ET, Meltzer MI, Global TravEpiNet Consortium, , 2014. Economics of malaria prevention in US travelers to West Africa. Clin Infect Dis 58: 1121.[Crossref]
  21. Angell SY, Cetron MS, , 2005. Health disparities among travelers visiting friends and relatives abroad. Ann Intern Med 142: 6772.[Crossref]
  22. van Genderen PJ, van Thiel PP, Mulder PG, Overbosch D, Dutch Schiphol Airport Study Group, , 2012. Trends in the knowledge, attitudes and practices of travel risk groups towards prevention of malaria: results from the Dutch Schiphol Airport Survey 2002 to 2009. Malar J 11: 179.[Crossref]
  23. Pistone T, Guibert P, Gay F, Malvy D, Ezzedine K, Receveur MC, Siriwardana M, Larouzé B, Bouchaud O, , 2007. Malaria risk perception, knowledge and prophylaxis practices among travellers of African ethnicity living in Paris and visiting their country of origin in sub-Saharan Africa. Trans R Soc Trop Med Hyg 101: 990995.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0565
Loading
/content/journals/10.4269/ajtmh.15-0565
Loading

Data & Media loading...

  • Received : 06 Aug 2015
  • Accepted : 29 Aug 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error